Literature DB >> 15677876

The Mayo Clinic family study of Parkinson's disease: study design, instruments, and sample characteristics.

Walter A Rocca1, Brett J Peterson, Shannon K McDonnell, James H Bower, J Eric Ahlskog, Daniel J Schaid, Demetrius M Maraganore.   

Abstract

We describe here the Mayo Clinic Family Study of Parkinson's disease (PD), including the overall study design (historical cohort study of relatives from birth to onset of PD or censoring), the data collection instruments, the strategies implemented to prevent or measure biases, and the sample obtained. These methodological details may provide assistance to other investigators designing studies of the familial aggregation of PD or other aging-related chronic diseases. We investigated the incidence of PD and other neurodegenerative diseases among 1,001 first-degree relatives of 162 patients with PD and 851 relatives of 147 controls representative of the population of Olmsted County, Minn., USA. In addition, we studied 2,713 first-degree relatives of 411 patients with PD referred to the Mayo Clinic. Finally, we studied a group of 625 spouses of either cases or controls. Relatives with PD or other neurodegenerative diseases were ascertained using the family study method. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15677876     DOI: 10.1159/000083612

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  11 in total

1.  Gender differences in the risk of familial parkinsonism: beyond LRRK2?

Authors:  R Saunders-Pullman; K Stanley; M San Luciano; M J Barrett; V Shanker; D Raymond; L J Ozelius; S B Bressman
Journal:  Neurosci Lett       Date:  2011-04-12       Impact factor: 3.046

2.  Risk factors for Parkinson's disease may differ in men and women: an exploratory study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  Horm Behav       Date:  2012-06-08       Impact factor: 3.587

3.  Common variants in PARK loci and related genes and Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Sarah J Lincoln; Alexandra I Ortolaza; Matthew J Farrer; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2010-12-13       Impact factor: 10.338

4.  Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca
Journal:  Int J Epidemiol       Date:  2012-11-18       Impact factor: 7.196

5.  Mood and cognition in leucine-rich repeat kinase 2 G2019S Parkinson's disease.

Authors:  Vicki Shanker; Mark Groves; Gary Heiman; Christina Palmese; Rachel Saunders-Pullman; Laurie Ozelius; Deborah Raymond; Susan Bressman
Journal:  Mov Disord       Date:  2011-05-24       Impact factor: 10.338

6.  Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP).

Authors:  Walter A Rocca; Brandon R Grossardt; Scott M Brue; Cynthia M Bock-Goodner; Alanna M Chamberlain; Patrick M Wilson; Lila J Finney Rutten; Jennifer L St Sauver
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

7.  Variants in estrogen-related genes and risk of Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Julie M Cunningham; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2011-04-05       Impact factor: 10.338

8.  Genomic determinants of motor and cognitive outcomes in Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Kari J Anderson; Timothy G Lesnick; David N Rider; Julie M Cunningham; J Eric Ahlskog; Roberta Frigerio; Demetrius M Maraganore
Journal:  Parkinsonism Relat Disord       Date:  2012-05-30       Impact factor: 4.891

9.  Anxious personality predicts an increased risk of Parkinson's disease.

Authors:  James H Bower; Brandon R Grossardt; Demetrius M Maraganore; J Eric Ahlskog; Robert C Colligan; Yonas E Geda; Terry M Therneau; Walter A Rocca
Journal:  Mov Disord       Date:  2010-10-15       Impact factor: 10.338

10.  Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.

Authors:  Maurizio F Facheris; Nicole K Schneider; Timothy G Lesnick; Mariza de Andrade; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2008-10-30       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.